
|Articles|February 5, 2008
New label approved to reflect Thrombin-JMI manufacturing changes
FDA approves revised labeling for Thrombin-JMI.
Advertisement
Enhanced processes to reduce Factor V light chain content to undetectable levels during the manufacture of
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Addressing Depression Symptoms Can Significantly Improve Asthma Outcomes
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
What the Newest Landmark PBM Reform Means for the Pharmacy Industry
4
Q&A: How Direct-to-Consumer Pharmacies Could Affect the Pharmacy Landscape
5























